Outcomes in Patients with Interstitial Lung Disease Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors

被引：0
|
作者：
Dobre, I. [1 ]
Frank, A. J. [2 ]
D'Silva, K. M. [2 ]
Okin, D. [2 ]
Sharma, A. [2 ]
Montesi, S. B. [2 ]
机构：
[1] Queens Univ, Sch Med, Kingston, ON, Canada
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7795
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
    Brinch, Charlotte Margareta
    Hogdall, Estrid
    Junker, Niels
    Moeller, Holger Jon
    Sandfeld-Paulsen, Birgitte
    de Heer, Pieter
    Penninga, Luit
    Rossen, Philip Blach
    Krarup-Hansen, Anders
    Aggerholm-Pedersen, Ninna
    CANCERS, 2022, 14 (23)
  • [42] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
  • [43] Overshadowed prospect of programmed cell death protein-1 (PD-1) inhibitor as monotherapy for patients with advanced hepatocellular carcinoma
    Yao, Xu
    Wang, Lei
    Gao, Jianjun
    BIOSCIENCE TRENDS, 2019, 13 (03) : 282 - 283
  • [44] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [45] Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: A propensity score-matched study.
    Tian, Yaru
    Lu, Shuangqing
    Sun, Yulan
    Tang, Xiaoyong
    Sun, Zhuoran
    Zhao, Ke
    Du, Guochang
    Li, Wanjing
    Zhu, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 206 - 206
  • [46] Systemic effect of radiotherapy (RT) followed by programmed death 1 (PD-1) inhibitors in non-small-cell lung cancer (NSCLC).
    Bassanelli, Maria
    Giannarelli, Diana
    Gelibter, Alain
    Cecere, Fabiana Letizia
    Chiari, Rita
    Giacinti, Silvana
    Scagnoli, Simone
    Milella, Michele
    Ricciuti, Biagio
    Roberto, Michela
    Magri, Valentina
    Ferraresi, Virginia
    Brambilla, Marta
    Santarelli, Mario
    Marchetti, Paolo
    Cortesi, Enrico
    Ceribelli, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [47] Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer
    Jove, Maria
    Vilarino, Noelia
    Nadal, Ernest
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S364 - S368
  • [48] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [49] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [50] PROGRAMMED CELL DEATH PROTEIN (PD-1) BLOCKADE IN ADVANCED AND METASTATIC SQUAMOUS CELL CARCINOMA OF THE SKIN
    Vaidya, P.
    Lin, S.
    In, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A196 - A196
12345